From May 1, 2023 to July 31, 2023, the company has repurchased 101,000 shares, representing 0.75% for $0.6 million. With this, the company has completed the repurchase of 115,000 shares, representing 0.85% for $0.68 million under the buyback announced on April 5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.615 USD | -3.25% | +2.10% | -17.88% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
1st Jan change | Capi. | |
---|---|---|
-17.88% | 64.84M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.